Sign in

CIK 0001061983 · Large accelerated filer

CYTOKINETICS INC

Sign in to watch
Ticker
CYTK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
943291317
Phone
(650) 624-3000
Business address
350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Planned sale EVP Research & Development sold 3,500 shares at $65.69 ($229,915)
  2. ARS Other Annual Report to Security Holders
  3. DEF 14A Proxy Proxy Statement
  4. 4 Grant or award Director acquired 95 shares (grant or award)
  5. 4 Grant or award Director acquired 95 shares (grant or award)
  6. 4 Grant or award Director acquired 191 shares (grant or award)
  7. 4 Grant or award Director acquired 325 shares (grant or award)
  8. 4 Grant or award Director acquired 191 shares (grant or award)
  9. 4 Grant or award Director acquired 191 shares (grant or award)
  10. 4 Planned sale EVP, Chief Commercial Officer sold 7,449 shares at $66.02 ($491,783)
  11. 4 Planned sale President & CEO sold 7,500 shares at $65.38 ($490,350)
  12. 144 Insider Sale of Securities
  13. 4 Planned sale EVP Research & Development sold 4,500 shares at an average $65.11 ($292,985)
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 4 Planned sale President & CEO sold 7,500 shares at $66.63 ($499,725)
  17. 144 Insider Sale of Securities
  18. 4 Planned sale EVP, Chief Commercial Officer sold 3,639 shares at $65.00 ($236,535)
  19. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  20. 4 Open-market sale EVP, Chief Financial Officer sold 4,935 shares at $62.15 ($306,710)

Page 6 of 127 · 2,534 filings